Naimish Patel serves as Chief Medical Officer at CRISPR Therapeutics AG, where they oversee executive responsibilities. Since joining the company, Naimish Patel has executed 1 insider transactions totaling $49.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 3, 2025 involved purchasing 1,508 shares valued at $49.7K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 3, 2025 | CRSP | $49.7K | Purchase | 1,508 | $32.96 | Discretionary |
Naimish Patel currently holds 1,508 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Naimish Patel has been a net buyer of CRSP stock. They have purchased $49.7K and sold $0 worth of shares.
Naimish Patel's most recent insider trade was on Apr 3, 2025, when they purchased 1,508 shares at $32.96 per share.
Get notified when new Form 4 filings are submitted